We use EBITDASO, a non-GAAP measure, internally for our operating, budgeting and financial planning purposes and as a metric for our Company-wide Milestone Incentive Bonus Program, and believe our investors' understanding of our performance is enhanced by disclosing this measure.
The presentation of these non-GAAP financial measures is not to be considered in isolation or as a substitute for our financial results prepared in accordance with GAAP.
Statements included in this press release that are not historical in
nature are "forward-looking statements" within the meaning of the Private
Securities Reform Act of 1995. These forward-looking statements include our
expectations and intentions regarding the payment of federal and state
income taxes for 2007, the generation of taxable income, the availability
and utilization of net operating loss carryforwards to reduce taxable
income, and the availability, creation and utilization of research tax
credits to pay income taxes that are based on our current beliefs and
expectations as to future outcomes. These forward-looking statements are
subject to certain risks and uncertainties, such as those described in our
periodic reports filed with the Securities and Exchange Commission, which
could cause actual results to differ materially from anticipated results.
Consequently, such forward- looking statements are qualified by the
cautionary statements, cautionary language and risk factors set forth in
our periodic reports and documents filed with the Securities and Exchange
|SOURCE United Therapeutics Corporation|
Copyright©2007 PR Newswire.
All rights reserved